1. Market Research
  2. > Cancer Industry

carcinoma Industry, June 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Therapy, Renal Cancer, Cancer, Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Breast Cancer, Cervical Cancer, Digestive System Disorder, Bladder Cancer, Dermatological Condition, Molecular Diagnostic, Prostate Cancer.


 
1-10 of about 100 reports for Carcinoma

Purchase Reports From Reputable Market Research Publishers

Treatment of Midline Tract Carcinoma Involving NUT Gene - Patent Overview in the years 2011 - 2016

Treatment of Midline Tract Carcinoma Involving NUT Gene - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Nut midline carcinomas are uncommon carcinomas characterized by chromosomal rearrangements that involve the gene encoding the nuclear protein of the testis (NUT). The malignancies range from entirely ...

Treatment of Basal Cell Carcinoma - Patent Overview in the years 2011 - 2016

Treatment of Basal Cell Carcinoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

BCCs are abnormal, uncontrolled growths or lesions that arise in the skin’s basal cells, which line the deepest layer of the epidermis (the outermost layer of the skin). BCCs often look like open sores, ...

Treatment of Squamous Cell Carcinoma - Patent Overview in the years 2011 - 2016

Treatment of Squamous Cell Carcinoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Squamous cell cancer may occur in the undamaged skin. Or, it can occur in skin that has been injured or inflamed. Most squamous cell cancers occur on skin that is regularly exposed to sunlight or othe ...

Treatment of Carcinoma of Unknown Primary - Patent Overview in the years 2011 - 2016

Treatment of Carcinoma of Unknown Primary - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Rosetta Genomics Ltd. (NASDAQ - ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announced last year that the Company received a Notice of Allowance from the United States ...

Treatment of Ductal Carcinoma In Situ (DCIS) - Patent Overview in the years 2011 - 2016

Treatment of Ductal Carcinoma In Situ (DCIS) - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Ductal carcinoma in situ (DCIS) means the cells that line the milk ducts of the breast have changed to look like cancer cells under a microscope, but they have not spread into surrounding breast tissue. ...

Treatment of Thymoma and Thymic Carcinoma - Patent Overview in the years 2011 - 2016

Treatment of Thymoma and Thymic Carcinoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Thymoma and thymic carcinoma are diseases in which malignant (cancer) cells form on the outside surface of the thymus.The thymus, a small organ that lies in the upper chest under the breastbone, is part ...

Treatment of Adrenocortical Carcinoma - Patent Overview in the years 2011 - 2016

Treatment of Adrenocortical Carcinoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Adrenocortical carcinomas (ACCs) are rare and frequently aggressive tumors that may be functional (hormone-secreting) and cause Cushing's syndrome and/or virilization, or nonfunctional and present as an ...

Treatment of Merkel Cell Carcinoma - Patent Overview in the years 2011 - 2016

Treatment of Merkel Cell Carcinoma - Patent Overview in the years 2011 - 2016

  • $ 500
  • Industry report
  • June 2016
  • by Mordor Intelligence LLP

Merkel cells are found in the top layer of the skin. These cells are very close to the nerve endings that receive the sensation of touch. Merkel cell carcinoma, also called neuroendocrine carcinoma of ...

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • June 2016
  • by Global Data

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule, a part ...

Renal Cell Carcinoma - Pipeline Review, H1 2016

Renal Cell Carcinoma - Pipeline Review, H1 2016

  • $ 2 000
  • Industry report
  • May 2016
  • by Global Markets Direct

Renal Cell Carcinoma - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape. ...

About 6 100 reports for Carcinoma

Download Unlimited Documents from Trusted Public Sources

IHC - Company Report, 2015

  • January 2015
    259 pages
  • Lymphoma  

    Cancer  

    Breast Cancer  

View report >

Therapy Market

February 2015

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.